PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-11.16%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-14.27%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-19.78%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-21.40%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-24.91%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-25.00%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-24.83%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.21%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.21%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
16.89%
Dividend growth of 16.89% while QRVO is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-11.95%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-13.67%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
48.40%
10Y revenue/share CAGR 1.25-1.5x QRVO's 34.94%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
14.96%
5Y revenue/share CAGR under 50% of QRVO's 231.66%. Michael Burry would suspect a significant competitive gap or product weakness.
4.75%
3Y revenue/share CAGR under 50% of QRVO's 19.80%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
133.26%
10Y OCF/share CAGR under 50% of QRVO's 895.61%. Michael Burry would worry about a persistent underperformance in cash creation.
54.69%
Below 50% of QRVO's 636.47%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
35.00%
3Y OCF/share CAGR 1.25-1.5x QRVO's 25.52%. Bruce Berkowitz might see if strategic cost controls or product mix drove recent gains.
117.46%
Below 50% of QRVO's 314.33%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
45.49%
Below 50% of QRVO's 7433.67%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
9.10%
Below 50% of QRVO's 371.95%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
21.96%
Below 50% of QRVO's 279.39%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
-3.83%
Negative 5Y equity/share growth while QRVO is at 703.79%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-9.21%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
651.36%
Dividend/share CAGR of 651.36% while QRVO is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
165.01%
Dividend/share CAGR of 165.01% while QRVO is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
79.91%
Below 50% of QRVO's 486.41%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
-19.97%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-1.91%
Inventory is declining while QRVO stands at 10.08%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
0.14%
Asset growth above 1.5x QRVO's 0.03%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-0.66%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-0.20%
We’re deleveraging while QRVO stands at 28.68%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
1.85%
R&D growth drastically higher vs. QRVO's 2.60%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
3.26%
We expand SG&A while QRVO cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.